American Heart Association Comment: Nonsurgical Reconstruction Of Thoracic Aortic Dissection By Stent-Graft Placement

May 19, 1999

Two papers published in the May 19 issue of the New England Journal of Medicine suggest that a nonsurgical technique is safe and effective for treating people with aortic dissection, a condition that begins with a tear injury that progressively expands through the aorta, the large artery carrying blood from the heart to the rest of the body.

Aortic dissection is one of the most dangerous diseases of the aorta. In the U.S., about 10 to 20 cases per million people occur annually. If the condition is left untreated, 36 to 72 percent of patients die within 48 hours of diagnosis, and 62 to 91 percent die within one week.

The nonsurgical technique, catheter-delivered stent-graft placement, involves insertion of a wire mesh tube known as a stent to force open and maintain the opening of the blocked aorta.

Until now, people with aortic dissection have typically been treated with surgery or drugs. However, treatment is often followed by severe complications such as rupture of the aorta and death.

"This nonsurgical technique is currently being used in various medical centers to repair aortic dissections. However, these two studies are significant because they are the first to include a sizeable group of patients and to be conducted in a carefully-controlled, scientific manner with consistent collection of data and reporting of results," says Valentin Fuster, M.D., Ph.D., president of the American Heart Association and director of the Cardiovascular Institute, Mount Sinai Medical Center in New York City.

"In order to realize the full potential benefit of this nonsurgical technique for treating people with life-threatening aortic dissection, physicians must recognize the necessity of it being performed by a multidisciplinary team representing various medical specialties, including excellent imaging technology for visualizing the aorta," adds Fuster.

"Although the early results of the stent treatment are promising, the technique must be tested in additional, carefully controlled studies of larger population groups before it can become a recommended treatment for some types of aortic dissection," Fuster continued.
-end-


American Heart Association

Related Stent Articles from Brightsurf:

In-stent thrombosis after antiplatelet therapy conversion while awaiting coronary bypass
In a new publication from Cardiovascular Innovations and Applications; DOI https://doi.org/10.15212/CVIA.2019.0589, Nathan Burke, Tawanna Charlton, Hussam Hawamdeh, and Ki Park from the University of Florida College of Medicine, Gainesville, Florida, USA consider a case study of in-stent thrombosis after antiplatelet therapy conversion while awaiting coronary bypass.

Late coronary stent thrombosis in patient with COVID-19
This case report describes a patient with COVID-19 who developed late drug-eluting stent thrombosis.

Randomization of provisional vs two-stent techniques in complex bifurcation lesions
Aim: The present study aimed to assess the benefits of two-stent techniques for patients with DEFINITION criteria-defined complex coronary bifurcation lesions.

Leg pain medication may prevent re-blockage of neck arteries after a stent
Adding cilostazol, an antiplatelet medication for leg pain, to other drugs tended to prevent re-blockage of carotid artery stents within two years.

The world's smallest stent
Researchers at ETH Zurich have developed a new method for producing malleable microstructures -- for instance, vascular stents that are 40 times smaller than previously possible.

Type of stent affects immediate and long-term outcomes
A new study comparing the outcomes of different types of stents used to treat cerebral aneurysms shows that the type of stent used affects a patient's immediate and long-term health outcomes.

Stopping DAPT after one-month improved outcomes in stent patients
Patients who stopped taking aspirin one month after receiving a stent in the heart's arteries but continued taking the P2Y12 inhibitor clopidogrel fared significantly better after one year compared with those who followed the standard practice of continuing both medications, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Sugary stent eases suturing of blood vessels
A team led by the University of Nebraska-Lincoln and Harvard Medical School has concocted a sugar-heavy stent to reduce the margin of error in a delicate surgical procedure.

Non-invasive stent monitoring techniques tested
Barcelona researchers develop a probe to detect and monitor metallic stents.

Stent retriever thrombectomy effective for longer window after stroke
A new study shows promising real-world outcomes for patients receiving a stent retriever thrombectomy six hours after they experience an acute ischemic stroke (AIS).

Read More: Stent News and Stent Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.